Wells Fargo’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$797K Sell
33,844
-9,474
-22% -$223K ﹤0.01% 3501
2025
Q1
$1.04M Buy
43,318
+3,742
+9% +$89.9K ﹤0.01% 3240
2024
Q4
$1.67M Buy
39,576
+27,573
+230% +$1.17M ﹤0.01% 2927
2024
Q3
$531K Sell
12,003
-475
-4% -$21K ﹤0.01% 3594
2024
Q2
$451K Sell
12,478
-673
-5% -$24.3K ﹤0.01% 3637
2024
Q1
$567K Buy
13,151
+3,519
+37% +$152K ﹤0.01% 3469
2023
Q4
$148K Sell
9,632
-22,771
-70% -$350K ﹤0.01% 4259
2023
Q3
$444K Buy
32,403
+18,960
+141% +$260K ﹤0.01% 3585
2023
Q2
$216K Buy
13,443
+9,236
+220% +$148K ﹤0.01% 4304
2023
Q1
$32.6K Buy
+4,207
New +$32.6K ﹤0.01% 5096
2022
Q4
Sell
-231
Closed -$5K 7391
2022
Q3
$5K Sell
231
-112
-33% -$2.42K ﹤0.01% 5601
2022
Q2
$5K Sell
343
-2,612
-88% -$38.1K ﹤0.01% 5734
2022
Q1
$69K Sell
2,955
-2,742
-48% -$64K ﹤0.01% 5181
2021
Q4
$152K Buy
5,697
+5,650
+12,021% +$151K ﹤0.01% 5040
2021
Q3
$1K Buy
47
+19
+68% +$404 ﹤0.01% 6471
2021
Q2
$0 Buy
+28
New ﹤0.01% 7066